SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,130
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Compugen Appoints Senior Vice President Corporate and Business Development "PR Newswire (US)" - 12/5/2016 7:00:00 AM
Compugen to Present at 28th Annual Piper Jaffray Healthcare Conference in New York "PR Newswire (US)" - 11/21/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/14/2016 6:10:49 AM
Compugen Immune Checkpoint Program Demonstrates Potential for Development of New Cancer Immunotherapy Treatments "PR Newswire (US)" - 11/11/2016 11:45:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 11/7/2016 7:11:46 AM
Compugen Ltd. Reports 3rd Quarter 2016 Financial Results "PR Newswire (US)" - 11/7/2016 7:07:00 AM
Compugen to Host R&D Day on December 7, 2016 in New York "PR Newswire (US)" - 11/3/2016 9:53:00 AM
Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) "Edgar (US Regulatory)" - 10/14/2016 4:03:33 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 10/12/2016 6:05:48 AM
Compugen Third Quarter Financial Statements to be Released November 7, 2016 "PR Newswire (US)" - 10/10/2016 7:00:00 AM
Compugen to Present at the Annual Meeting of the Society for Immunotherapy of Cancer Next Month "PR Newswire (US)" - 10/7/2016 7:00:00 AM
Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid Targets for Cancer Immunother... "PR Newswire (US)" - 8/30/2016 7:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 8/25/2016 10:13:31 AM
Securities Registration (foreign Private Issuer) (f-3) "Edgar (US Regulatory)" - 8/9/2016 6:32:18 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/9/2016 6:12:43 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/2/2016 7:02:10 AM
Compugen Ltd. Reports 2nd Quarter 2016 Financial Results "PR Newswire (US)" - 8/2/2016 7:01:00 AM
Compugen Second Quarter 2016 Conference Call Scheduled for Tuesday, August 2, 2016 at 10:00 AM ET "PR Newswire (US)" - 7/21/2016 7:00:00 AM
Compugen Discloses Lead Therapeutic Candidate for CGEN-15029 Immuno-Oncology Program "PR Newswire (US)" - 6/22/2016 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/22/2016 7:02:52 AM
Compugen to Present at JMP Securities Life Sciences Conference in New York "PR Newswire (US)" - 6/15/2016 7:00:00 AM
Compugen to Present at the Jefferies Global Healthcare Conference in New York "PR Newswire (US)" - 5/23/2016 7:00:00 AM
Compugen to Present at the Oppenheimer Annual Israeli Conference in Tel Aviv "PR Newswire (US)" - 5/16/2016 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/10/2016 7:05:21 AM
Compugen Ltd. Reports First Quarter 2016 Financial Results "PR Newswire (US)" - 5/10/2016 7:01:00 AM
DAD2   Tuesday, 02/07/12 07:23:17 AM
Re: Penny Roger$ post# 111
Post # of 153 
Yep its posted:

Zero revenues in the 4th quarter and the net loss for the 4th quarter was $4.4 million.

Might pull back slightly imo.

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist